Study Details
Long term study of solifenacin succinate and tamsulosin hydrochloride Oral Controlled Absorption System (OCAS) in males with lower urinary tract symptoms
Clinicaltrials.gov ID
Astellas Study ID
905-CL-057
EudraCT ID
N/A
Condition
Bladder Disease, Enlarged Prostate
Phase
Phase 3
Age
45 years - N/A
Sex
Male
Product
N/A
Type
Interventional
Trial Dates
Apr 2010 - Dec 2011
Masking
None (Open Label)
Enrollment number
1067
An open-label, long term, multi-center study to assess the safety and efficacy of fixed dose combinations of solifenacin succinate (6 mg and 9 mg) with tamsulosin hydrochloride OCAS 0.4 mg, in male subjects with lower urinary tract symptoms (LUTS) associated with benign prostatic hyperplasia (BPH) with a substantial storage component
Study summary
Study documents
Get More Information
Would you like more information about clinical trial sites that are recruiting participants for Long term study of solifenacin succinate and tamsulosin hydrochloride Oral Controlled Absorption System (OCAS) in males with lower urinary tract symptoms? Contact us by filling our your information to the right and we’ll respond to you.